NOVEMBER 2026 INDUSTRY DEEP DIVE

Veterinary Diagnostics for Livestock in Low-Income Regions: Demand Without Distribution

Why livestock exposure and disease pressure do not translate into diagnostic demand on their own, using farmer, laboratory and surveillance evidence from Uganda, Malawi and comparator countries.

Published: November 5, 2026
Read time: 23 min
Data cut-off: Nov 4, 2026
Source: World Bank, FAO, WOAH, peer-reviewed studies, NextMSC analysis

RESEARCH SNAPSHOT

61.6%

Uganda farmers who never submitted a sample (53 of 86)

73.3%

Uganda farmers citing lab location or access (63 of 86)

5.0%

Malawi FAO SET active-surveillance score

6.2%

Kenya farmers who paid for a test (5 of 81; comparator)

Study samples are small and are not national estimates. Kenya and Cambodia are lower-middle-income comparators. No market size is estimated, and all prices are in USD.

KEY TAKEAWAYS

  • Need and use are different variables. In a Ugandan survey, 61.6% of farmers (53 of 86) had never submitted a sample to a laboratory, even though the same laboratories reported strong requests for culture and susceptibility testing (15 of 16 lab personnel).
  • Distance and service reliability come first. Farmers cited laboratory location or access (73.3%), staff availability (60.5%), affordability (58.1%) and turnaround time (53.5%). These are multiple-response shares and must not be added.
  • Capability gaps are specific. Only 2 of 16 Ugandan laboratories had an ELISA reader, and 4 of 16 personnel reported requests for rapid tests that were not available.
  • System capacity is thin even in a national review. Malawi scored 5.0% for active surveillance and 25.4% for the laboratory domain on the FAO SET, with 228 assistant veterinary officer posts vacant against about 700 surveillance personnel.
  • No market size can be supported. Livestock headcount, disease reports and test requests do not give incidence, testing rates, channel reach or USD prices, so this analysis leaves the bottom-up model unpopulated on purpose.

2026 Market Pulse Metrics

Micro-indicators from peer-reviewed studies and national assessments. Study samples are not national estimates.

UGANDA FARMERS WHO NEVER SUBMITTED

61.6%

53 of 86 respondents; 2021 study sample.

LAB PERSONNEL REQUESTED CULTURE + AST

93.8%

15 of 16 in Uganda; a test few labs could run.

REQUESTED RAPID TESTS NOT AVAILABLE

25.0%

4 of 16 lab personnel (CBPP, FMD, Newcastle, mycoplasma).

LABS WITH AN ELISA READER

12.5%

2 of 16 participating Ugandan laboratories.

MALAWI FAO SET LABORATORY SCORE

25.4%

Operational 41.6, technical 24.1, analytical 22.2.

MALAWI VACANT AVO POSTS

228

Of about 700 surveillance personnel; roughly one-third.

Executive Summary

The commercial story for veterinary diagnostics in low-income regions is usually told from the demand side: large livestock populations, endemic disease and a rising emphasis on animal health. The evidence assembled here points to a different constraint. Demand, in the sense of need, is plentiful. But the steps between a sick animal and a usable test result, which include awareness, a reachable provider, a staffed laboratory, a correctly collected and transported sample, a test that is actually on the menu, and a result delivered in time, are where most of the loss occurs.

The strongest direct evidence is a 2021 Ugandan survey. Of 86 farmers, 53 (61.6%) had never submitted a sample to a laboratory. Farmers cited laboratory location or access (73.3%), staff availability (60.5%), affordability (58.1%) and turnaround time (53.5%) as factors affecting submission. Meanwhile, animal health workers did use laboratories: 86.0% (49 of 57) had submitted at least one sample in the previous six months, and 21.1% submitted more than three times a month. The laboratories themselves reported unmet requests. Fifteen of 16 laboratory personnel said clients asked for culture and antimicrobial susceptibility testing, yet only two of 16 participating laboratories had an ELISA reader.

Malawi's 2026 FAO assessment of its national animal-health surveillance system adds a system view. It scored active surveillance at 5.0% and the laboratory domain at 25.4%, found 228 vacant assistant veterinary officer posts against about 700 surveillance personnel, and reported that the Central Veterinary Laboratory was not accredited and had no electronic laboratory information system. These are capacity scores, not test adoption rates, but they explain why test demand in the field may not be served.

Two comparators, Kenya and Cambodia, are lower-middle-income and are kept separate. In Kenya, only 5 of 81 farmers (6.2%) reported paying for a diagnostic test in the previous year, although 48.8% had a sick animal in the previous three months. In Cambodia, about half of smallholder households (50.6%) reported no access to any veterinary provider.

Our reading: demand and distribution should be analyzed as separate variables. The workbook deliberately does not convert livestock headcount into a market size, because incidence, testing rates, channel reach and USD prices are not available for the sample countries. What the evidence can quantify is the conversion gap, and it points to distribution, staffing, test menus and trust as the binding constraints.

Evidence tierMaterial includedUse in this articleDo not infer
Direct micro evidenceUganda 2021 farmer, animal-health-worker and laboratory survey; Malawi FAO SET assessment (published 2026); Kenya laboratory study (published 2026)Measured utilization, access barriers, capability and network constraintsThat small samples describe every low-income country
LIC exposure panel2024 cattle-stock estimates and 2024 rural electricity access for 10 low-income countriesLivestock scale and infrastructure contextThat cattle stock is total livestock or addressable demand; that electricity access means laboratory uptime
Comparator evidenceCambodia 2026 smallholder service survey; Kenya cost and use studyAdjacent distribution patterns and USD pricesThat comparators are low-income economies
System-level evidenceWOAH laboratory cohort and PVS framework; FAO EMPRES-iSustainability and event-reporting contextThat global cohort metrics are LIC-specific; that missing events mean no disease

Source: NextMSC micro-indicator dataset (November 4, 2026).

Livestock Exposure vs. Infrastructure Readiness

The ten-country panel pairs 2024 cattle stock with 2024 rural electricity access for selected African economies classified as low income in the World Bank's FY2027 list. It is an illustrative panel and not a complete list of low-income economies, and it covers cattle only, so it does not represent goats, sheep, pigs or poultry. Rural electricity access is an infrastructure proxy. It is not a measure of laboratory or cold-chain uptime.

CountryCattle stock (million head)Share of panel cattleRural electricity access, 2024Access gap (pp)
Ethiopia71.954.5%44.8%55.2
Niger20.415.5%10.8%89.2
Uganda14.711.2%44.8%55.2
Burkina Faso10.37.8%12.7%87.3
Madagascar75.3%26.5%73.5
Mozambique2.51.9%12.3%87.7
Malawi2.31.7%6.4%93.6
Congo, Dem. Rep.21.5%1.0%99.0
Sierra Leone0.6820.5%24.9%75.1
Liberia0.0430.0%9.2%90.8

Sources: FAOSTAT-origin 2024 cattle stock via Africa API (secondary display); World Bank WDI/ESMAP rural electricity access, 2024. Shares are NextMSC calculations. Cattle stock is context, not diagnostic demand.

Figure 1. Cattle Stock, Ten Low-Income Countries (million head, 2024)

Source: FAOSTAT-origin data via Africa API and NextMSC analysis.nextmsc.com/industry-deep-dive/veterinary-diagnostics-livestock-low-income-regions-2026

The panel holds 131.8 million cattle. Ethiopia accounts for 54.5% of that and Niger 15.5%, followed by Uganda (11.2%), Burkina Faso (7.8%) and Madagascar (5.3%). Livestock scale and infrastructure do not line up. Rural electricity access runs from 1.0% in the Democratic Republic of the Congo to 44.8% in Ethiopia and Uganda, and the six countries where access is below 15% (the DRC, Niger, Burkina Faso, Malawi, Mozambique and Liberia) hold 37.5 million head, or 28.5% of the panel's cattle.

Figure 2. Rural Electricity Access, 2024 (% of rural population)

Source: World Bank WDI / ESMAP and NextMSC analysis.nextmsc.com/industry-deep-dive/veterinary-diagnostics-livestock-low-income-regions-2026

The comparison matters for diagnostics because many tests need power, refrigeration for reagents and samples, and reliable connectivity for results. A country with a large cattle population and low rural electricity access can have substantial disease pressure and still lack the enabling conditions for decentralized testing. The panel does not show test demand or laboratory availability, but it shows why headcount alone is a poor guide.

Farmer Uptake and the Barriers to Using Laboratories

The Ugandan study surveyed 86 farmers, 57 animal health workers and 16 laboratory personnel, along with key informants. It is cross-sectional and is not a national estimate, but its denominators are preserved and it is the most detailed direct evidence in the dataset.

IndicatorRespondent groupCountDenominatorShare
Never submitted a sample to a laboratoryFarmers538661.6%
Laboratory location or access citedFarmers (multiple response)638673.3%
Laboratory staff availability citedFarmers (multiple response)528660.5%
Affordability citedFarmers (multiple response)508658.1%
Sample turnaround time citedFarmers (multiple response)468653.5%
Submitted a sample in the previous six monthsAnimal health workers495786.0%
Submitted more than three times a monthAnimal health workers125721.1%

Source: Frontiers in Veterinary Science (2021), Uganda survey. Shares are calculated from the study numerators and denominators. Barrier shares are multiple-response and must not be summed.

Figure 3. Barriers to Submitting Samples, Ugandan Farmers (% citing, n = 86)

Source: Frontiers in Veterinary Science (2021) and NextMSC analysis.nextmsc.com/industry-deep-dive/veterinary-diagnostics-livestock-low-income-regions-2026

The ranking of barriers is informative. Location and access come first, which implies that sample collection and travel distance matter more than price. Staff availability, cited by 60.5%, means a nominally open laboratory may not be serviceable for field clients. Affordability (58.1%) is cited by more than half of farmers but it is not a measured price elasticity, and the study does not give an absolute price. Turnaround time (53.5%) reduces the usefulness of a result for a decision about a sick animal.

The contrast between farmers and animal health workers matters for distribution. Professional intermediaries submit often, while most farmers do not submit at all. In this sample the demand that exists runs through animal health workers, so a diagnostics channel that reaches those intermediaries can reach a part of the market that farmers do not reach directly. The two figures are not strictly comparable, because the farmer measure is whether a farmer ever submitted a sample and the animal-health-worker measure is submission in the previous six months, but the direction is clear.

Laboratory Capability: Requested Tests vs. Available Tests

Laboratory personnel in the Ugandan study described a pattern of requested tests that exceeded what laboratories could provide. Culture and susceptibility testing was the most requested service, followed by serology, blood smears, post-mortem examination and complete blood counts.

Service or equipmentPersonnel reporting requests or presenceRequested but unavailable
Culture and antimicrobial susceptibility testing93.8% (15 of 16)18.8% (3 of 16)
Serology68.8% (11 of 16)12.5% (2 of 16)
Blood smear68.8% (11 of 16)n/a
Post-mortem examination62.5% (10 of 16)n/a
Complete blood count56.3% (9 of 16)12.5% (2 of 16)
Rapid tests (CBPP, FMD, Newcastle disease, mycoplasma)n/a25.0% (4 of 16)
Toxicology and acaricide analysisn/a25.0% (4 of 16)
Microscope available75.0% (12 of 16 laboratories)n/a
ELISA reader available12.5% (2 of 16 laboratories)n/a

Source: Frontiers in Veterinary Science (2021). Shares are calculated from the study numerators and denominators; "n/a" means the study did not report that cell. Equipment presence does not prove functionality.

Figure 4. Tests Requested but Unavailable, Ugandan Laboratories (% of 16 personnel)

Source: Frontiers in Veterinary Science (2021) and NextMSC analysis.nextmsc.com/industry-deep-dive/veterinary-diagnostics-livestock-low-income-regions-2026

Microscopy is common (75.0% of laboratories had a microscope), while molecular and immunoassay platforms are scarce (two ELISA readers across 16 laboratories). That fits the pattern of blood smears and parasitology being routine and confirmatory serology being constrained. The study also describes more than six regional veterinary laboratories and two national diagnostic laboratories as supported through national and FAO initiatives. That is a support footprint, not a current inventory of functional laboratories.

The gap between requests and availability is a distribution signal. Laboratories were being asked for tests they could not always provide, and the unavailable categories (rapid tests, toxicology, culture and susceptibility testing) are the ones that depend on supplies, equipment and trained staff. The study also reports insufficient supplies and high reagent costs. A laboratory that exists but cannot keep reagents in stock is not a reliable distribution node.

Malawi: What a National Capacity Assessment Shows

Malawi's assessment used the FAO Surveillance Evaluation Tool, a participatory method with 96 indicators, site visits and stakeholder input across seven districts. The paper was published in June 2026, and the scores are system-capacity ratings. They are not shares of farms tested or measures of test adoption.

Figure 5. Malawi FAO SET Scores (% score)

Source: BMC Veterinary Research / FAO (Malawi assessment, 2026) and NextMSC analysis.nextmsc.com/industry-deep-dive/veterinary-diagnostics-livestock-low-income-regions-2026

Active surveillance scored 5.0%, the lowest of the areas reported, which means planned and targeted sampling is minimal. Internal communication scored 12.6% and risk assessment 16.7%. The laboratory domain scored 25.4% overall, with operational aspects (41.6%) stronger than technical (24.1%) and analytical (22.2%) ones. A laboratory that is operating but technically and analytically weak can produce results, though not necessarily results a field veterinarian or farmer will trust or act on.

Workforce and network

The study reports about 700 surveillance personnel nationally and 228 vacant assistant veterinary officer positions, which it describes as approximately one-third. The Central Veterinary Laboratory has 13 technicians supporting eight veterinarians, is not accredited, and has no electronic laboratory information management system. Two regional laboratories, in Blantyre and Mzuzu, provide basic diagnostics. Laboratory capacity is centralized, so samples from most districts must travel to reach a testing hub.

Taken together, the indicators describe a network in which the field layer (staff for detection and sample collection) and the testing layer (staffed, accredited, digitally tracked laboratories) are both thin. For a diagnostics supplier, selling a test into that environment depends on whether someone is positioned to collect the sample, route it and return the result, not only on whether the test is available.

Comparators: Kenya and Cambodia

Kenya and Cambodia are classified as lower-middle-income and are kept outside the core low-income sample. They are useful because they measure parts of the chain that the low-income studies do not, notably payment, sample transport and provider access.

Kenya

A 2026 study of public and private veterinary laboratories, based on fieldwork from October 2023 to February 2024 in Kiambu and Kajiado counties, surveyed 86 farmers, 40 animal health service providers, 11 laboratory managers and 2 regulators. Of the farmers, 48.8% (42 of 86) had at least one sick animal in the previous three months, but only 6.2% (5 of 81) paid for a diagnostic test in the previous 12 months. The two figures use different time windows and denominators, so they are not a conversion rate, but they show the scale of the gap between need and paid use. Providers used laboratories far more: 95.0% (38 of 40) had ever sent samples, though only 28.9% (11 of 38) had done so in the previous three months, and 52.5% (21 of 40) had sent samples for bacteriology and susceptibility testing.

IndicatorValueBasis
Farmers with a sick animal in the previous 3 months48.8%42 of 86
Farmers who paid for a test in the previous 12 months6.2%5 of 81
Providers who ever sent samples95.0%38 of 40
Providers who sent samples in the previous 3 months28.9%11 of 38
Samples moved by private vehicle81.0%17 of 21 submitters
Samples moved by courier9.5%2 of 21 submitters
Laboratory pickup used9.5%2 of 21 submitters
Laboratories using an electronic LIMS72.7%8 of 11
Laboratories sharing AMR data with epidemiology unit27.3%3 of 11

Source: One Health Outlook (2026), Kenya laboratory study. Calculated shares use the study numerators and denominators.

Figure 6. Kenya ATLASS Laboratory Scores (% score, comparator)

Source: One Health Outlook (2026), Kenya laboratory study and NextMSC analysis.nextmsc.com/industry-deep-dive/veterinary-diagnostics-livestock-low-income-regions-2026

The ATLASS assessment of 11 laboratories gave a quality-assurance score of 57.58% and an activity score of 53.03%, but a molecular-tools score of 0% and a sustainability score of 33.31%. The study attributes laboratory underuse to limited awareness, sample-transport logistics, cost, long turnaround time, failure to receive results and low trust. Most samples (81%) moved by private vehicle, which suggests ad hoc logistics rather than a formal system.

Cambodia

A 2026 survey of 1,528 smallholder households across ten provinces measured service access, not diagnostics. About 49.4% of households reported access to any veterinary provider, which leaves 50.6% without, and 18.5% used a veterinary service in the previous year. A village animal health worker was accessible to 36.1% of households and was the most used provider for 12.4%.

Figure 7. Cambodia Smallholder Veterinary Service Access and Use (% of 1,528 households)

Source: Journal of Rural Studies (2026), Cambodia survey and NextMSC analysis.nextmsc.com/industry-deep-dive/veterinary-diagnostics-livestock-low-income-regions-2026

Poultry shows the species gap. Households keeping poultry were 86.0% of the sample, but poultry received only 15.0% of veterinary services. Diagnostic access is downstream of provider access, so a market where half of households have no veterinary provider cannot support a diagnostic channel until the provider layer exists, which is why village-level workers appear in both the Cambodian and the Ugandan evidence as the most reachable layer.

Disease Signals and the Test Menu

The disease matrix is a demand-signal and test-menu summary. It is not a prevalence ranking, and disease-specific sample sizes, case counts and incidence are not inferred from diagnostic requests.

Disease or conditionLivestockSignal in the field studyTest service lineObserved gap
East Coast fever / theileriosisCattleAmong the diseases most often tested in UgandaBlood smear, microscopy, serologyDependable confirmatory testing needs validation
BrucellosisCattle, sheep, goatsFrequently reported need; laboratories asked for ELISA expansionRose Bengal test, serology, ELISAOnly two laboratories reported ELISA readers
Foot-and-mouth diseaseCattle, pigs, sheep, goatsPriority disease; among tests laboratories could not provideRapid tests, specialized serology4 of 16 reported requested rapid tests unavailable (the source percentage for FMD is inconsistent and is not used)
CBPPCattlePriority disease for animal health professionalsRapid test, serologyRapid-test availability gap
PPRSheep, goatsLaboratories wished to test but could notSpecialized serology, rapid viral testsKit supply and regional access need mapping
African swine feverPigsSwine disease cited by key informantsSerology, molecularConfirmation is a reported service gap
Newcastle diseasePoultryRapid test requested but unavailable in some laboratoriesRapid viral testsRapid-test availability gap
Mastitis (Kenya comparator)Dairy cattleMost common reason for laboratory confirmation by providersBacteriology and ASTTransport, cost and turnaround constraints

Source: Frontiers in Veterinary Science (2021) for Uganda; One Health Outlook (2026) for Kenya. A request or a reported inability to test is a capability signal, not a prevalence estimate.

Two patterns recur. First, the diseases most associated with testing demand (tick-borne disease, brucellosis, helminthiasis, mastitis) are served by established, relatively simple service lines such as microscopy and serology, while the diseases laboratories most often could not test (foot-and-mouth disease, CBPP, peste des petits ruminants, African swine fever, Newcastle disease) need rapid tests, specialized serology or molecular platforms. Second, the rapid-test category is where unmet requests concentrate in the Ugandan study, which is the category most dependent on supply continuity and trained users in the field.

Last-Mile Bottlenecks and Possible Responses

The evidence separates access barriers, operating capability and purchasing behavior. Each barrier below is measured in a study, but the responses listed beside them are analytical suggestions and have not been tested in these settings.

BottleneckObserved factEvidencePossible response (analytical, not measured)
Physical access73% of farmers cite laboratory location or accessUganda, 63 of 86District collection points; scheduled pickups; community animal-health-worker referral
Affordability58% of farmers cite affordabilityUganda, 50 of 86Subsidized first-line panels; pooled or cooperative testing; transparent prices
Turnaround53% of farmers cite turnaround timeUganda, 46 of 86Hub-and-spoke courier routes; rapid tests where clinically suitable; service-level targets
Staff60% of farmers cite staff availability; 228 AVO posts vacant in MalawiUganda, 52 of 86; MalawiRosters, referral hotlines, after-hours sample windows
Test menu25% of personnel report requested rapid tests unavailableUganda, 4 of 16Prioritize validated rapid tests for CBPP, FMD, Newcastle disease and mycoplasma where clinically appropriate
Reagents and suppliesInsufficient supplies and high reagent costs reportedUganda (qualitative)Framework contracts, buffer stock, distributor replenishment
Network topologyCapacity centralized; two regional laboratories offer basic servicesMalawiDefined referral to central testing hubs
Digital systemsNo electronic LIMS at the Central Veterinary LaboratoryMalawiLightweight offline-first sample tracking and result notification
Sample transport81% by private vehicle; 9.5% courierKenya comparator, 17 of 21Contracted courier days, motorbike routes, cold-box protocols
Provider access50.6% of households with no provider accessCambodia comparatorVillage-level referral with laboratory escalation

Sources: Uganda, Malawi, Kenya and Cambodia studies. The last column is NextMSC analysis of possible responses and is not an observed programme outcome.

The bottlenecks interact. Physical access determines whether a sample reaches a laboratory at all. Staff availability and the test menu determine whether it can be processed. Turnaround and reporting determine whether the result is useful. A response to one barrier will not work if the next one is unaddressed, for example a courier route to a laboratory that cannot run the requested test.

Price Evidence in USD

Price evidence is thin, and all of it is in USD. Neither the Ugandan nor the Malawian study reports an absolute test price, so the dataset leaves those fields blank and carries no local-currency values.

CountryGroupObservationMinimumMaximumNotes
Kenya (comparator)Farmers (n = 86)Farmer-reported diagnostic service cost$0$14Excludes transport; 5 of 81 reported paying; zero reflects free or subsidized services
Kenya (comparator)Animal health service providers (n = 40)Provider-reported diagnostic service cost$0$20Excludes transport; broad range across services, not a standard test price
Uganda (LIC)Farmers, animal health workersDiagnostic test pricenot reportednot reportedAffordability is cited as a barrier but no absolute price is given
Malawi (LIC)National assessmentDiagnostic test pricenot reportednot reportedCapacity constraints reported; no price

Source: One Health Outlook (2026) for Kenya; Uganda and Malawi studies for the not-reported rows. The Kenya ranges are a comparator, not a low-income price benchmark.

The Kenya ranges illustrate two points. A range from $0 to $14 at the farmer level shows that some testing is free or subsidized and that stated prices vary by service. A range up to $20 at the provider level shows that providers report higher figures, probably reflecting different services and facilities. Neither is an average selling price, and transport costs are excluded. The dataset therefore does not support using these ranges as a unit-price assumption for any low-income country.

Why This Analysis Does Not Size the Market

A bottom-up demand estimate needs five inputs for each country and species: an annual disease or syndrome event rate, the share of events where testing is indicated, the share reachable through a diagnostic channel, tests per indicated event, and an average selling price. The workbook includes a calculation shell with livestock stock filled in and every other input blank.

CountrySpeciesLivestock stock (head)Event rateTesting indicatedChannel reachTests per eventPrice (USD/test)
EthiopiaCattle71,900,000blankblankblankblankblank
NigerCattle20,400,000blankblankblankblankblank
UgandaCattle14,700,000blankblankblankblankblank
Burkina FasoCattle10,300,000blankblankblankblankblank
MadagascarCattle7,000,000blankblankblankblankblank
MozambiqueCattle2,500,000blankblankblankblankblank
MalawiCattle2,300,000blankblankblankblankblank
Congo, Dem. Rep.Cattle2,000,000blankblankblankblankblank
Sierra LeoneCattle682,000blankblankblankblankblank
LiberiaCattle43,000blankblankblankblankblank

Source: NextMSC dataset. Expected tests = stock x event rate x share indicated x share reachable x tests per event; revenue = tests x price. No output is shown because no validated inputs exist.

The model is empty on purpose. The cited evidence offers no validated country-specific incidence, testing indication, channel reach or price for the sample countries, and cattle stock is not total livestock. Multiplying a headcount by an assumed rate would produce a number that looks precise and has no evidential basis. The studies in this analysis measure related quantities, such as how many farmers had submitted a sample or which tests laboratories could run, but none of them can be converted into those inputs without further assumptions.

The practical consequence is that any claim about the size of the diagnostics market in these countries should be treated cautiously. Filling the model requires primary data: surveys of incidence and testing intent, a mapping of provider reach, and price collection in USD. Until then, the better question is not how large the market is but what fraction of the plausible need is reachable at all.

System-Level Context: WOAH, PVS and Disease Reporting

WOAH's PVS Sustainable Laboratories cohort covers 19 countries and 171 laboratories across four regions and reports more than 27 million tests a year. It is a global reference for national laboratory networks, not a low-income sample, and its figures should not be divided by low-income livestock populations. WOAH's programme findings are relevant to this analysis in one respect: capacity-building gains can be underused or inefficient when laboratories are built without the full operating model of reagents, staff, maintenance, transport and demand generation, and service delivery is more expensive in lower-income settings because of low sample throughput, high import costs and waste.

WOAH's PVS Pathway is a standardized evaluation of 45 critical competencies of national veterinary services, and more than 140 countries have engaged with it. Engagement is not the same as measured diagnostic access. WOAH's 2026 State of the World's Animal Health report, which evaluated 54 members twice, reports that only four met minimum capacity across all competencies and that 76% improved overall capacity between evaluations, a pattern of progress that still leaves most systems below the minimum.

FAO's EMPRES-i collects event-based disease reports, primarily from WOAH's WAHIS and supplemented by FAO and partners. The data reflect reporting, so a missing event is not evidence that a disease is absent, and the dataset makes no inference about incidence from them. The reporting chain depends on the same laboratory and surveillance capacity that this analysis finds to be thin, which is a reason for caution in using disease-event counts as a demand indicator.

Implications for Diagnostics Suppliers, Distributors, Funders and Governments

The implications below follow from the evidence and are NextMSC interpretation. They are not tested programme results.

For diagnostics suppliers

The evidence favors tests that fit the observed constraints: rapid, minimal-equipment formats for the diseases laboratories most often could not test, with clear sample-handling instructions and supply continuity. A product designed for a well-equipped laboratory will meet the same limits as the ELISA reader shortage (2 of 16 laboratories). Pairing a test with a route to collect and return samples, or with a way for a village-level worker to use it, addresses the access and turnaround barriers that farmers cite most.

For distributors and logistics partners

The Kenyan transport data (81% by private vehicle) and the Ugandan access barrier (73.3%) point to an open logistics layer. The Malawian network (two regional laboratories, one central laboratory without an electronic tracking system) suggests that lightweight sample tracking and scheduled pickups may add more value than additional testing capacity in places where samples do not arrive.

For funders and programmes

WOAH's finding that capacity gains can go underused is consistent with the Ugandan and Malawian evidence: laboratories exist, but staff vacancies, reagent supply and missing quality systems limit what they deliver. Funding laboratories without funding the operating model is likely to leave the conversion gap unchanged. Measuring uptake, such as the share of farmers who have submitted a sample or the share of requested tests available, is a more direct outcome than counting laboratories.

For national governments

The Malawi scores suggest that surveillance planning and laboratory technical capacity are separate gaps. Active surveillance at 5.0% limits how many samples enter the system, and a laboratory domain at 25.4% limits what can be done with them. Coordinated attention to both, together with field staffing, is likely to matter more than any single investment.

Outlook and What to Watch

The evidence base is small and dated for the low-income countries, so the main outlook is about what data would change the picture.

More low-income farmer surveys

The Ugandan survey dates from 2021 and covers one country. Repeating it in Ethiopia, Niger or Burkina Faso, where cattle stock is large, would show whether the pattern holds.

USD price collection

No low-income price is reported. Collecting test prices, including transport, is a prerequisite for any revenue model.

Species coverage

The panel covers cattle only. Small ruminants, pigs and poultry carry much of the disease burden in the evidence and are not captured by stock data here.

Operating-model evidence

Studies that measure reagent availability, turnaround and result delivery over time would show whether capacity gains translate into service.

Dataset Explorer

Filter the micro-indicators behind this analysis by domain, or search by country, indicator or source. Study samples are not national estimates, and comparator countries are marked.

DomainCountry / scopeIndicatorYearValueBasisSource

Sources: World Bank, FAOSTAT-origin data via Africa API, Frontiers in Veterinary Science, BMC Veterinary Research, One Health Outlook, Journal of Rural Studies, WOAH and NextMSC analysis. Kenya and Cambodia are lower-middle-income comparators.

Methodology and Source Notes

Data cut-off: November 4, 2026. Planned refresh: when new national surveys, FAO SET assessments or WOAH PVS evaluations are published.

Scope

The core panel is ten African economies on the World Bank's FY2027 low-income list (gross national income per capita of US$1,175 or less). It is a selected panel, not all 25 low-income economies. Kenya and Cambodia are lower-middle-income and are used only as comparators. Cattle stock comes from FAOSTAT-origin 2024 estimates displayed by a secondary source and should be checked against a direct FAOSTAT export before formal ranking.

Calculations

Shares are calculated from study numerators and denominators, which are preserved. Barrier shares from the Ugandan survey are multiple-response and are not summed. Malawi's FAO SET results are scores, not adoption rates. The 228 vacant assistant veterinary officer posts are reported against about 700 surveillance personnel as approximately one-third, and no vacancy ratio is recalculated across incompatible job categories. The share of panel cattle in low-access countries is cattle in countries with rural electricity access below 15% divided by total panel cattle.

Currency

All prices are in USD, as reported by the source. No local-currency values are carried, and no conversions are performed.

Known flags

  • The Ugandan study reports foot-and-mouth disease as unable-to-test for 5 of 16 personnel with a percentage that does not match (5 of 16 is 31.25%). The percentage is not used.
  • The Malawi assessment is a participatory scoring exercise across seven districts and is published in 2026.
  • The WOAH cohort is a pooled global sample, not low-income specific.
  • EMPRES-i reflects reporting, so missing events are not zero disease.

Frequently Asked Questions

How big is the diagnostics market for livestock in low-income countries?

This analysis does not estimate it. Incidence, testing eligibility, channel reach and USD prices are not available for the sample countries, and livestock headcount alone would not support a number.

Why do farmers not use laboratories?

In the Ugandan survey, farmers cited laboratory location or access (73.3%), staff availability (60.5%), affordability (58.1%) and turnaround time (53.5%). These are multiple-response shares.

What does the Malawi 5% score mean?

It is the FAO SET score for active surveillance. It rates system capacity and is not the share of farms tested.

Are Kenya and Cambodia low-income countries?

No. Both are lower-middle-income. They are used as comparators for payment, transport and provider access.

Does cattle stock measure demand?

No. Cattle stock is context only, covers cattle but not other species, and does not measure disease incidence or test purchases.

What would make a market estimate possible?

Country-specific disease or syndrome event rates, the share of events where testing is indicated, the share reachable through a channel, tests per event and USD prices collected in the field.

Conclusion

Livestock exposure and disease pressure create a potential need for veterinary diagnostics in low-income regions, but they do not by themselves create demand that can be served. The Ugandan survey shows farmers who rarely use laboratories, laboratories that cannot run tests clients ask for, and barriers (distance, staff, cost, turnaround) that sit between the two. The Malawian assessment shows thin surveillance, a short supply of field and laboratory staff and a central laboratory without accreditation or electronic tracking. The comparators in Kenya and Cambodia show low paid use and large provider-access gaps in neighboring settings.

The most defensible conclusion is that demand and distribution are separate variables, and that the second is the binding constraint in the evidence reviewed. No market size can be estimated without country-specific incidence, testing, channel and price data. The useful work for suppliers, distributors, funders and governments is to measure and close the conversion gap, step by step.

About the Author

Mihul Sharma Mihul Sharma — Mihul Sharma is Research Associate at Next Move Strategy Consulting, where he has covered technology, industrial, and healthcare markets for 3 years. His work applies structured business research, market analysis, and secondary-source review to assess market trends, competitive developments, and growth opportunities. He supports report development by fully synthesizing industry data, company information, and market signals into concise findings for strategy and investment-focused research teams.

About the Reviewer

Debashree Dey Debashree Dey — Debashree Dey is Assistant Manager at Next Move Strategy Consulting, where she supports cross-vertical market content and communications across diverse industries for 6 years. Her professional background includes senior content writing, communications, and published manuscript authorship, with experience developing audience-focused business narratives and maintaining clear, consistent messaging. Her role supports research-led content development and editorial quality across NextMSC publications.

Data cut-off: November 4, 2026  •  Corrections and source challenges: Contact NMSC Research.

This website uses cookies to ensure you get the best experience on our website. Learn more

✖